NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/16/2026
Back to search
Official data from USPTO
DIRECTIONS IN ONCOLOGY PHARMACY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
DIRECTIONS IN ONCOLOGY PHARMACY
ST13
US500000088491893Class
16, 41
Filing
88491893
Registration
6015292
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
35
Latest update
04/17/2026
Trademark type
Word
Nice classes
16, 41
Filing date
06/27/2019
Registration date
03/17/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/16/2026
Last transaction
04/17/2026
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
09/30/2019
First use in commerce
09/30/2019
Drawing code
4
Owner type
16
Owner location
Cranbury, NJ, US
Examiner
EDWARDS, ALICIA COLLINS
Current location
Historical data usage
Holders and representatives
Holders
Pharmacy and Healthcare Communications, LLC
Representatives
Shannon Hennessy Pulaski THE LAW OFFICE OF SHANNON HENNESSY PULASKI, LLC
Technical classification
Nice Classes
Class 16Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 16
Publicationsjournalsnewslettersmonographsarticlesprinted supplements to such printed publications in the field of medicine
Class 41
Educational servicesproviding continuing education courses and annual conferences in the field of medicine; Providing a website featuring non-downloadable publications in the nature of journalsnewslettersmonographsarticles in the field of medicine
Publications
History of USPTO decisions and trademark events.
35 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/16/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/16/2026
E815
TEAS SECTION 8 & 15 RECEIVED
01/22/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/01/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
11/01/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
11/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/27/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/27/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/27/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/27/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/27/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/17/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
03/17/2020
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
02/12/2020
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/11/2020
SUPC
STATEMENT OF USE PROCESSING COMPLETE
01/15/2020
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
01/15/2020
IUAF
USE AMENDMENT FILED
01/02/2020
EISU
TEAS STATEMENT OF USE RECEIVED
01/02/2020
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/24/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/29/2019
PUBO
PUBLISHED FOR OPPOSITION
10/29/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/09/2019
ALIE
ASSIGNED TO LIE
09/25/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/19/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/18/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/18/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/17/2019
GNRT
NON-FINAL ACTION E-MAILED
09/17/2019
CNRT
NON-FINAL ACTION WRITTEN
09/17/2019
DOCK
ASSIGNED TO EXAMINER
09/17/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/08/2019
NWAP
NEW APPLICATION ENTERED
07/01/2019
Continuous trademark protection
Get notified about every new filing that threatens DIRECTIONS IN ONCOLOGY PHARMACY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.